Metoprolol Pharmaclan (Metoprolol Tartrate)

Metoprolol Tartrate selectively blocks β1‑adrenergic receptors in the heart. This inhibition reduces heart‑rate, myocardial contractility and cardiac output, leading to lower blood pressure and decreased oxygen demand by the heart muscle, which is beneficial in treating the listed cardiovascular conditions.

The appropriate dose of Metoprolol Pharmaclan is determined by the prescribing healthcare professional based on the patient’s specific condition, response to therapy and any concomitant medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of Metoprolol Pharmaclan in pregnancy or while breastfeeding has not been definitively established. Healthcare providers will weigh potential benefits against possible risks before prescribing it to pregnant or nursing individuals. Patients should discuss their situation with a qualified clinician.

To order Metoprolol Pharmaclan, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metoprolol Pharmaclan is a selective β1‑blocker, offering cardiac‑specific effects with fewer respiratory side‑effects compared with non‑selective beta‑blockers. Compared with agents like atenolol, metoprolol has a shorter half‑life and may require twice‑daily dosing, but both share similar efficacy in lowering blood pressure and heart rate.

Metoprolol Pharmaclan should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Metoprolol Pharmaclan is taken orally, usually with or without food as directed by the prescriber. Tablets should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed by a healthcare professional.

Serious risks include severe bradycardia, marked hypotension, heart block, bronchospasm in patients with reactive airway disease, and rare allergic reactions such as angioedema. Patients should seek immediate medical attention if they experience fainting, extreme fatigue, difficulty breathing or swelling of the face or throat.

Metoprolol Pharmaclan is contraindicated in patients with severe bradycardia, second‑ or third‑degree AV block without a pacemaker, overt heart failure decompensation, and those with known hypersensitivity to metoprolol or any excipients. Caution is also advised for individuals with asthma, COPD, or uncontrolled diabetes.